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Abstract
Introduction: Fruit extract of Tribulus terrestris (TT) bears aphrodisiac and antioxidative properties. Antimicrobial drug, metro-
nidazole (MTZ) impairs the spermatogenic activity and fertility in males.  
Objective:  Validation of  the use of  fruit extract of  TT as a supplement against MTZ-induced fertility impairment in males. 
Methods: Adult Swiss strain male mice were administered with 500mg/kgBW/day of  MTZ for 28 days.  Low (100mg/kgBW/
day) and high (200mg/kgBW/day) doses of  TT were administered simultaneously with MTZ (500mg/kgBW/day) for same 
duration. All males were cohabited with virgin proestrus females. Vaginal plug formation was observed to calculate the libido 
index. Cohabited females were sacrificed on fifteenth day of  gestation to dissect out the ovaries and uteri. Fertility index, quantal 
pregnancy, pre-implantation and post-implantation losses were calculated. 
Results: MTZ-treated males showed unaltered mating ability, however, the females impregnated by such males exhibited marked 
alterations in the fertility index, quantal pregnancy and pre- and post-implantation losses. Supplementation with low dose of  TT 
failed to restore such reproductive toxicities exhibited by administration of  MTZ. However, the altered reproductive toxicities 
were reinstated to control values following supplementation with high dose of  TT. 
Conclusion: The fruit extract of  TT may emerge as an effective herbal remedy, correcting the drug-induced fertility impair-
ments in males.
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Herbal extracts are well established for infertility therapy 
and fertility regulation. The role of  certain herbs in im-
proving the reproductive impairments is well document-
ed.1-2 Tribulus terrestris (TT) has emerged as a new source 
of  antioxidant for infertility therapy.3 It is a flowering 
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plant, belonging to family Zygophyllaceae4 and bears sev-
eral pharmacological properties.5-7 This indigenous herb 
is also used in the Indian and Chinese system of  medicine 
for the treatment of  various reproductive disorders, espe-
cially in the males.8-10 The fruit of  TT contains a number 
of  different chemical substances including saponins, gly-
cosides, flavonoids, alkaloids, resins, tannins, sugar, sterols 
and essential oil.11-12  Among the saponins isolated from 
the fruit extract of  TT, protodioscin is the most popular 
active substance present in the extract,13-14 bearing aph-
rodisiac property.10 The existence of  antioxidative flavo-
noid compound in the ethanolic fruit extract of  TT has 
also been well documented.15-16 Our earlier findings have 
reported safety evaluation of  the fruit extract of  TT on 
the male reproductive health of  the laboratory mouse.17 
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Further, ameliorating potentiality of  TT has been proved 
against cadmium chloride-18, cypermethrin-19 and diabe-
tes-20 induced testicular injury in the rat.
Impairments in spermatogenic activity and fertility21 and 
sperm morphology and fertility22 of  the male mice follow-
ing administration of  MTZ, in our earlier findings, raised 
the scope to carry out a supplementation study using the 
fruit extract of  TT in order to ameliorate its side-effects. 
Metronidazole (MTZ) is the first nitroimidazole,23 used 
for the treatment of  Helicobacter pylori infections, amoebi-
asis, giardiasis, trichomoniasis, vaginal infections, antibi-
otic-associated pseudomembranous colitis, symptomatic 
amoebiasis24 and Crohn’s disease.24-25  Earlier findings 
have suggested the intervention of  metronidazole  on 
the male reproductive health and fertility of  laboratory 
rodents.26-34 The drug at the dose of  500mg/kg BW/day, 
administered for 4 weeks, is reported to impair spermato-
genic activity21 and sperm morphology and fertility22 in 
the  mice.
Our earlier findings have reported the beneficial proper-
ties of  TT in ameliorating the MTZ-induced spermato-
genic inhibition, arising as a consequence of  oxidative 
stress in the testis35 and alterations in the histopathology 
of  the epididymis36 in the mice. These observations raised 
the possibility that the interrupted fertility in male mice21 
may also be corrected using the fruit extract of  TT. Thus, 
the present study was designed with the aim to ascertain 
the use of  the fruit extract of  TT against MTZ-induced 
fertility impairment in the male mice.
Materials and Methods
Experimental animals
Thirty adult Swiss strain male mice (12 weeks old), and 
sixty adult Swiss strain female mice (10-12 weeks old), 
weighing 25-30g, were used in the study. All the mice 
were housed under standard husbandry conditions of  
temperature (24 ± 20ºC), light (photoperiod of  14 hours 
light and 10 hours dark) and relative humidity (60 to 
70%), in polypropylene cages, with rice husk as the bed-
ding material. Animals were maintained on pelleted food 
and water ad libitum. The use of  the mice was approved by 
the Animal Ethical Committee, Banaras Hindu Universi-
ty, Varanasi, India (No. Dean/11-12/CAEC/263).
Drug
MTZ (purchased from CDH, India) was dissolved in dou-
ble distilled water and administered orally. The fruit of  
TT was purchased from the local market of  Varanasi and 
got identified from the Department of  Botany, Banaras 
Hindu University (Voucher No. Zygo-2013-1). The ex-
tract of  the fruit was prepared by adopting the method of  
Hussain and co-authors10 and dissolved in distilled water 
for administration.
Dose selection
The human therapeutic dose of  MTZ was selected and 
translated to mice.37 The doses of  TT were standardized 
according to its ameliorating efficacy on MTZ-induced 
impairments in the fertility of  the male mice.
Experimental design
The animals were divided into six groups of  five each 
in which Group I and II served as untreated and vehi-
cle-treated (distilled water) controls, respectively. Mice of  
Group III were administered with MTZ (500mg/kg BW/
day) while that of  Group IV were administered with the 
fruit extract of  TT (200mg/kg BW/day), for 28 consec-
utive days.  Mice of  Groups V and VI were co-adminis-
tered with MTZ (500mg/kg BW/day) and both doses of  
the fruit extract of  TT (100mg/kg BW/day and 200mg/
kg BW/day), respectively, for 28 consecutive days.
Mating ability and fertility test
Five males of  each group were caged separately with two 
virgin proestrus females for overnight and according to 
the presence of  vaginal plug and implantation sites in fe-
males, the mating ability and fertility of  the males were 
assessed, respectively. The females impregnated with the 
treated males were weighed on the fifteenth day of  ges-
tation and sacrificed by cervical dislocation. The ovaries 
were removed to count the number of  corpus luteum. 
To determine the total number of  implantation sites, the 
uteri were dissected out and placed in 10% ammonium 
sulfide solution, which stained the hemosiderin pigment 
of  resorbed implanted sites blue black.38 The numbers of  
live implants, as well as the pre- and post-implantation 
losses were noted.
Calculation
Libido index (%) = Total no. of  males mated with fe-
males ÷ Total no. of  males caged with females X 100
Fertility index (%) = Total no. of  pregnant females ÷ To-
tal no. of  females exposed for mating X 100
Quantal pregnancy (%) = Total no. of  pregnant females ÷ 
Total no. of  females mated with the males X 100
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Pre-implantation loss  =  Corpus luteum – (Total no. of  
resorbed implants + Total no. of  live implants + Total no. 
of  dead implants)
 
Post-implantation loss  =  Total no. of  resorbed implants 
+ Total no. of  dead implants
 
Statistical analysis
Percentage values of  libido index, quantal pregnancy and 
fertility index were analyzed by using Chi-square test. The 
values of  the number of  live implants as well as pre- and 
post-implantation losses were represented as mean ± 
S.E. in each group and analyzed by ANOVA followed by 
Newman- Keul’s multiple range. Values were considered 
significant at p < 0.05.
Results
Libido index
The libido index of  all the treated mice remained unim-
paired, as compared with the controls (Table 1).
Fertility index
The females exhibited marked reduction in the fertility 
index to 25% when impregnated with the male mice, ad-
ministered with 500mg/kg BW/day of  MTZ (Table 1). 
This marked reduction was reinstated to 50% in the fe-
males, impregnated with the male mice, co-administered 
with 500mg/kg BW/day of  MTZ and 100mg/kg BW/
day of  the fruit extract of  TT and to 66.66% in the fe-
males impregnated with the male mice co-administered 
with 500mg/kg BW/day of  MTZ and 200mg/kg BW/
day of  the fruit extract of  TT (Table 1).
Quantal pregnancy
The females exhibited marked reduction in the quantal 
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Table 1. Effect of oral administration of MTZ and co-administration 
of MTZ and the fruit extract of TT for 28 consecutive days on the 




























































































Values are expressed in percentage. 
 a: significantly different from controls by Chi-square test at p < 0.05, b: significantly different from MTZ 
(500mg/kgBW/day) by Chi-square test at p < 0.05 
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pregnancy to 37.50% when impregnated with the male 
mice, administered with 500mg/kg BW/day of  MTZ 
(Table 1). This marked reduction was reinstated to ap-
proximately 71.42% in the females impregnated with the 
male mice co-administered with 500mg/kg BW/day of  
MTZ and 100mg/kg BW/day of  the fruit extract of  TT 
and to 88.88% in the females impregnated with the male 
mice co-administered with 500mg/kg BW/day of  MTZ 
and 200mg/kg BW/day of  the fruit extract of  TT (Table 
1).
Number of  live implants
The number of  live implants declined significantly in the 
females cohabited with the male mice, administered with 
500mg/kg  BW/day of  MTZ, as compared with the con-
trols (Table 2; Fig. 1B). The females impregnated with the 
male mice, co-administered with 500mg/kg BW/day of  
MTZ and 100mg/kg BW/day of  the fruit extract of  TT, 
did not show significant increase in the number of  live 
implants (Table 2; Fig. 1D). However, significant increase 
was noticed in the same in the females impregnated with 
the male mice, co-administered 500mg/kg BW/day of  
MTZ and 200mg/kg BW/day of  the fruit extract of  TT, 
as compared to those administered with 500mg/kg BW/
day of  MTZ (Table 2; Fig. 1E), thus attained the values 
similar to the controls.
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 Table 2. Effect of oral administration of MTZ and 
co-administration of  MTZ and the fruit extract of TT for 
28 consecutive days on the number of live implants, pre-implantation 
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Values are considered significant by ANOVA followed by Newman- Keul’s multiple range test at p < 0.05. 




    
         
 
 Fig. 1E 
Fig. 1 Implantation sites in the uterus of the female mice impregnated with (A.) the control male mice. Note the 
normal range of the numbers of implanted embryos in the left and right uteri.  (B.) the male mice administered 
with 500mg/kgBW/day of MTZ for 28 days. Note the post-implantation loss indicated by the least number of 
implanted embryos in the uterus, the dead implant (red arrow) and the resorption sites indicated by scars (black 
arrow) observed in the uterus devoid of implanted embryos. (C.) the male mice administered with 
200mg/kgBW/day of the fruit extract of TT for 28 days. Note the normal range of the numbers of implanted 
embryos in the left and right uteri. (D.) the male mice co-administered with MTZ (500mg/kgBW/day) and the fruit 
extract of TT (100mg/kgBW/day) for 28 days. Note the post-implantation loss indicated by the dead implant (red 
arrow), the partial recovery in the number of implanted embryos as the left and right uteri of one female was still 
devoid of implanted embryos. (E.) the male mice in Gr. VIII, co-administered with MTZ (500mg/kgBW/day) and the 
fruit extract of TT (200mg/kgBW/day) for 28 days. Note the recovery in the number of implanted embryos in the 
uterus. Also note a dead implant (red arrow) in the left uteri of two females. 
Fig. 1C 
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Pre-implantation loss
Females impregnated with the male mice administered 
with 500mg/kg BW/day of  MTZ showed a marked in-
crease in the pre-implantation loss, as compared to the 
controls (Table 2; Fig. 1B). However, this loss was re-
stored, comparable to the controls, only in the females 
impregnated with the males co-administered with 500mg/
kg BW/day of  MTZ and 200mg/kg BW/day of  the fruit 
extract of  TT (Table 2; Fig. 1E).
Post-implantation loss
Females impregnated with the male mice administered 
with 500mg/kg BW/day of  MTZ showed a marked in-
crease in the post-implantation loss, as compared to the 
controls (Table 2; Fig. 1B). However, a noticeable resto-
ration was noted by showing a decrease in such losses, 
comparable to the controls, only in the females impreg-
nated with the males co-administered with 500mg/kg 
BW/day of  MTZ and 200mg/kg BW/day of  the fruit 
extract of  TT (Table 2; Fig. 1E).
Discussion
The present study centres around the ameliorating po-
tentiality of  the fruit extract of  TT against MTZ-induced 
fertility impairment. The ameliorating fertilizing potenti-
ality was evidenced by evaluating the libido index, quan-
tal pregnancy, number of  live implants, pre-implantation 
loss and post-implantation loss.
In the present study, MTZ administration did not affect 
the libido index of  the mice. The libido index ranging 
between 80-90% suggests the unaltered mating ability of  
the mice, administered with 500mg/kg BW/day of  MTZ. 
Since, libido index is an androgen-dependent parameter38 
therefore, its unaltered range noticed in the present study 
reflects the optimal level of  serum testosterone in the 
mice administered with MTZ (500mg/kg BW/day). This 
reflection is supported by the unaltered level of  serum 
testosterone as reported in our earlier finding21.
Inspite of  the unaltered mating ability of  the treated 
males, significantly reduced number of  live implants, with 
profound elevation in the pre-implantation and post-im-
plantation losses were noted in the females, impregnated 
with the males, administered with 500mg/kg BW/day 
of  MTZ.  These findings suggest the impaired fertilizing 
potential of  the spermatozoa, which may be due to alter-
ations in the sperm quality. A high percentage of  sperm 
with progressive motility is related to high fertilization in-
dex.39 Therefore, the decline in the fertility index of  the 
females with reduced number of  live implants in the uteri 
might be due to severely depressed motility of  epididy-
mal spermatozoa in the mice administered with 500mg/
kg BW/day of  MTZ as reported in our earlier findings,36 
thus, suggesting an impaired  sperm transport in the re-
productive tract.
Further, the decline in quantal pregnancy indicates the 
anti-implantation effect of  MTZ. Pre-implantation losses 
might have arisen due to disruption of  events which are 
prerequisite for fertilization or an impairment in the pro-
duction of  cytokines, growth factor and various types of  
adhesion molecules either by the developing blastocyst 
or by the uterine epithelium around the site of  implan-
tation.40-42 The increase in the post-implantation loss fol-
lowing 500mg/kg BW/day of  MTZ administration may 
be attributed to the direct damage to the sperm DNA, 
caused by the free radicals or reactive oxygen species re-
leased by the inflammatory cells.42 The post-implantation 
loss may also be attributed to  the oxidative stress, pro-
duced in the testis of  MTZ-treated mice, as reported in 
our earlier study.35  
In the present study, fertility of  the MTZ-treated males 
was improved following co- administrations of  MTZ and 
200mg/kg BW/day of  the fruit extract of  TT, as evi-
denced by recovery in the fertility index, quantal pregnan-
cy, the number of  live implants and pre- and post-implan-
tation losses in the females impregnated with such males. 
Our earlier findings reporting the reappearance of  sev-
eral spermatozoa in the epididymal lumen, as evidenced 
through histopathological study, following co-adminis-
trations of  500mg/kg BW/day of  MTZ and 200mg/kg 
BW/day of  the fruit extract of  TT36, also support the 
present study. Therefore, improvements in the number 
of  live implants and pre- and post-implantation losses 
might be due to the beneficial properties exhibited by the 
fruit extract of  TT on the quality and quantity of  sper-
matozoa,43-47 thus increasing the fertility potential of  the 
MTZ-treated mice. 
Conclusion
MTZ, administered at the dose of  500mg/kg BW/day 
for 28 days impairs the fertility in the males. The fruit ex-
tract of  TT bears the potentiality to restore the impaired 
African Health Sciences Vol 18 Issue 3, September, 2018650
fertility and hence, may emerge as an effective herbal 
remedy in improving the drug-induced fertility impair-
ments in the males.
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